Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results; Patient Affordability Drives 40% Revenue Growth and Significant Margin Expansion

Stock Information for Paysign Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Paysign Inc.

Paysign to Host Fourth Quarter and Full Year 2025 Earnings Call
Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference
Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions
Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference
Paysign, Inc. Reports Third Quarter 2025 Financial Results
Paysign to Host Third Quarter 2025 Earnings Call
Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions
Paysign, Inc. Announces Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.